Ronald Todd Plott insider trades: Phio Pharmaceuticals (PHIO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronald reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | PHIO | ↑ Buy | 10,000 | $1.03 | $10K | Direct | Sep 30, 2026 (1d) |
| Aug 19, 2026 | PHIO | ↑ Buy | 15,000 | $1.14 | $17K | Direct | Aug 20, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PHIO insiders
Open-market trades in the last 12 months
About Ronald Todd Plott's insider trades
Ronald Todd Plott is a director at Phio Pharmaceuticals (PHIO). Since Aug 19, 2026, Ronald has reported 2 open-market purchases worth $27K and no sales on SEC Form 4. In the last 12 months: 2 buys ($27K).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.